About this journal

Aims and scope

The American Journal of Drug and Alcohol Abuse (AJDAA) is an international, interdisciplinary journal that is published six times per year. AJDAA provides a venue for researchers to disseminate clinically relevant research findings and innovative perspectives in the field of addiction. Topics published in AJDAA span preclinical to population-based analyses, including applied methodology, neurobiology, behavioral science, treatment, epidemiology, and public policy. The manuscripts generally present original data analyses or quantitative/narrative reviews of timely developments in our field. Manuscripts exploring behavioral addictions are encouraged. Reviews and Perspectives of emerging fields are given priority consideration. Papers are published on an ongoing basis.

Areas of particular interest include:

  • basic mechanisms
  • novel research methodologies
  • pharmacological, and social interventions, including innovative modalities
  • public health policy


Journal metrics

Usage

  • 193K annual downloads/views

Citation metrics

  • 2.7 (2023) Impact Factor
  • Q2 Impact Factor Best Quartile
  • 3.6 (2023) 5 year IF
  • 4.7 (2023) CiteScore (Scopus)
  • Q2 CiteScore Best Quartile
  • 0.810 (2023) SNIP
  • 0.794 (2023) SJR

Speed/acceptance

  • 28 days avg. from submission to first decision
  • 62 days avg. from submission to first post-review decision
  • 47 days avg. from acceptance to online publication
  • 33% acceptance rate

Editorial board

Editor-in-Chief
Bryon Adinoff - University of Colorado School of Medicine


Deputy Editors
Edythe D. London - University of California Los Angeles

Edward Nunes - Columbia University

Associate Editors

Brenda Curtis - National Institutes of Health*: Methods in Addiction Research and Big Data

Jennifer M. Reingle Gonzalez - The Meadows Mental Health Policy Institute and the University of Texas School of Public Health: Epidemiology and Behavioral Science

Ricardo Pautassi - Instituto de Investigaciones Médicas M. y M. Ferreyra (INIMEC-CONICET-UNC, Argentina): Preclinical

Sterling McPherson - Washington State University: Human Psychopharmacology

Social Media Editor

Walter Roberts - Yale University

Editorial Board

Gillinder Bedi - University of Melbourne and Orygen

Qiana Brown - Rutgers University

Miguel Ángel Cano - University of Texas Southwestern Medical Center

Ziva D. Cooper - University of California Los Angeles 

Craig Field - University of Texas El Paso 

Francesca Filbey – University of Texas Dallas

Marc Galanter - New York University School of Medicine

Albert Garcia-Romeu - Johns Hopkins University School of Medicine

Abhishek Ghosh - Postgraduate Institute of Medical Education and Research, Chandigarh, India 

Kanna Hayashi - Simon Fraser University

Jermaine D. Jones - New York State Psychiatric Institute and Columbia University Irving Medical Center

Lorenzo Leggio – National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse 

Leah M. Mayo - University of Calgary

R. Kathryn McHugh - McLean Hospital and Harvard Medical School

Scott J. Moeller - Stony Brook University School of Medicine

Miguel Pinedo - University of Texas at Austin

Lara Ray – University of California Los Angeles

Antonio Verdejo-Garcia - Monash University

Roger Weiss - Harvard University

Arthur Robin Williams - Columbia University and New York State Psychiatric Institute

T. John Winhusen - University of Cincinnati College of Medicine 
 
Statistical Editors: 

Celestina Barbosa-Leiker - Washington State University 

Grace Chan - University of Connecticut School of Medicine

James M. Henson - Old Dominion University 

Rod Knight, University of British Columbia: Qualitative and Mixed Methods

Allysha Maragh-Bass, Duke Global Health Institute: Qualitative and Mixed Methods

Christine Mauro - Columbia University 

Editorial Diversity Fellowship: 

Co-directors

Abhishek Ghosh - Postgraduate Institute of Medical Education and Research, Chandigarh, India

Leah M. Mayo - University of Calgary

2024 Fellows

Pedro Henrique Gobira, Aarhus University, Denmark

Tesfa M. Yimer, The University of Queensland, Australia

*Dr. Curtis is serving in a personal capacity 

Abstracting and indexing

AJDAA is Abstracted and/or indexed in: Academic Search Complete; Biological Abstracts; Biomedical Reference Collection: Comprehensive; BIOSIS Previews; Consumer Health Complete; Current Contents®/Social and Behavioral Sciences; EMBASE; EMCARE; ETOH; Health and Safety Abstracts; Journal Citation Reports/ Social Sciences Edition; PASCAL; Popline; PsychInfo; PubMed/MedLine; Risk Abstracts; Social Sciences Citation Index®; Sociological Abstracts; Social SciSearch; Social Services Abstracts; SCOPUS

Open access

The American Journal of Drug and Alcohol Abuse is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.

Use our APC finder to calculate your article publishing charge

News, offers and calls for papers

Advertising information

Would you like to advertise in The American Journal of Drug and Alcohol Abuse?

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in The American Journal of Drug and Alcohol Abuse.

Explore advertising solutions

Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors